777 abstracts found.



Results filter

BI-015 a novel diagnostic and prognostic prostate cancer biomarker that buffers the translational burden of neoplastic transformation

Year:

Session type:

Hayley Whitaker1,2, Jonathan Kay1, Anne Warren3, Ian Mills11, Benjamin Thomas1, Fredrik Wiklund5, Amanda Seipel4, Dan Berney6, Lars Egevad4, Gabrielle Fisher7, Chris Foster8, Colin Cooper10, Peter Scardino9, Jack Cuzick7, Henrik Gronberg5, David Neal1
1Uro-Oncology Group, Cancer Research UK Cambridge Institute, Cambridge, UK, 2Biomarker Initiative, Cancer Research UK Cambridge Institute, Cambridge, UK, 3Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK, 4Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden, 5Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden, 6The Orchid Tissue Laboratory, Centre for Molecular Oncology, Barts and The London School of Medicine and Dentistry, London, UK, 7Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, St Bartholomew’s Medical School, Queen Mary, University of London, London, UK, 8Department of Cellular Pathology and Molecular Genetics, Liverpool University Hospital, Liverpool, UK, 9Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, USA, 10Institute of Cancer, The Royal Marsden Hospital, Sutton, UK, 11Centre for Molecular Medicine, Oslo, Norway

Next-Generation Sequencing analysis for detecting Human Papillomavirus in oral verrucous lesions

Year:

Session type:

Manar Samman1, Henry Wood1, Monica Pentenero3, Alec High2, Pamela Rabbitts1
1Leeds Institute of Cancer Studies and Pathology, Section of Pre-Cancer Genomics, University of Leeds, Leeds, UK, 2Department of Histopathology, St. James’s University Hospital and Leeds Dental Institute, Leeds, UK, 3Department of Oncology, Oral Medicine and Oral Oncology Unit, University of Torino, Turin, Italy

How do patients fare in the real world? – Clinical practice outcomes of patients treated with Pazopanib for metastatic renal cell cancer

Year:

Session type:

Victoria Galvis1, Shien Chow1, Dionne Lawrence1, Robert Hawkins1
1The Christie Hospital, Manchester, UK

Agricultural land usage and bone cancer: Is there a link? Small-area analyses of osteosarcoma and Ewing sarcoma diagnosed in 0-49 year olds in Great Britain, 1985-2009

Year:

Session type:

Karen Blakey1, Richard Feltbower2, Roger Parslow2, Peter James1, Charles Stiller3, Paul Norman4, David Garthwaite5, Jacqueline Hughes6, Craig Gerrand7, Richard McNally1
1Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK, 2Paediatric Epidemiology Group, University of Leeds, Leeds, UK, 3Childhood Cancer Research Group, Department of Paediatrics, University of Oxford, Oxford, UK, 4School of Geography, University of Leeds, Leeds, UK, 5Food and Environment Research Agency, York, UK, 6Science and Advice for Scottish Agriculture, Edinburgh, UK, (NICR) Northern Institute for Cancer Research

Impact on a general hospital of the publication of National Institute for Health and Clinical Excellence (NICE) guidelines on diagnosis of epithelial ovarian cancer (EOC)  

Year:

Session type:

Abigail Ford1, Oliver Marshall1, S Michael Crawford1
1Airedale NHS Foundation Trust, Keighley, UK

Diagnostics challenges of gastrointestinal stromal tumours (GISTs) – tumours that mimic GISTS

Year:

Session type:

Nadeera De Silva1, Amy Kwan1, Daniel Holyoake1, Han Wong1, Ramesh Bulusu1
1Addenbrooke's Hospital, Cambridge, UK

Evaluation of the management of Hodgkin’s disease in Blida, Algeria

Year:

Session type:

Messaoud Ayad1, Kahina Rabahi1, Kada Boualga1
1Centre Anti-Cancer, Blida, Algeria

Page 78 of 78« First...25...78